SLP Long Call Strategy

SLP (Simulations Plus, Inc.), in the Healthcare sector, (Medical - Healthcare Information Services industry), listed on NASDAQ.

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions.

SLP (Simulations Plus, Inc.) trades in the Healthcare sector, specifically Medical - Healthcare Information Services, with a market capitalization of approximately $274.2M, a beta of 1.28 versus the broader market, a 52-week range of 11.09-34.01, average daily share volume of 338K, a public-listing history dating back to 1997, approximately 243 full-time employees. These structural characteristics shape how SLP stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.28 places SLP roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. SLP pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a long call on SLP?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current SLP snapshot

As of May 15, 2026, spot at $13.23, ATM IV 83.40%, IV rank 43.36%, expected move 23.91%. The long call on SLP below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long call structure on SLP specifically: SLP IV at 83.40% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 23.91% (roughly $3.16 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SLP expiries trade a higher absolute premium for lower per-day decay. Position sizing on SLP should anchor to the underlying notional of $13.23 per share and to the trader's directional view on SLP stock.

SLP long call setup

The SLP long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SLP near $13.23, the first option leg uses a $13.23 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SLP chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SLP shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$13.23N/A

SLP long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

SLP long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on SLP. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on SLP

Long calls on SLP express a bullish thesis with defined risk; traders use them ahead of SLP catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

SLP thesis for this long call

The market-implied 1-standard-deviation range for SLP extends from approximately $10.07 on the downside to $16.39 on the upside. A SLP long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current SLP IV rank near 43.36% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on SLP should anchor more to the directional view and the expected-move geometry. As a Healthcare name, SLP options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SLP-specific events.

SLP long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SLP positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SLP alongside the broader basket even when SLP-specific fundamentals are unchanged. Long-premium structures like a long call on SLP are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current SLP chain quotes before placing a trade.

Frequently asked questions

What is a long call on SLP?
A long call on SLP is the long call strategy applied to SLP (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With SLP stock trading near $13.23, the strikes shown on this page are snapped to the nearest listed SLP chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are SLP long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the SLP long call priced from the end-of-day chain at a 30-day expiry (ATM IV 83.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a SLP long call?
The breakeven for the SLP long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SLP market-implied 1-standard-deviation expected move is approximately 23.91%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on SLP?
Long calls on SLP express a bullish thesis with defined risk; traders use them ahead of SLP catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current SLP implied volatility affect this long call?
SLP ATM IV is at 83.40% with IV rank near 43.36%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related SLP analysis